Xiamen Amoytop Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Xiamen Amoytop Biotech has a total shareholder equity of CN¥2.0B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.4B and CN¥421.7M respectively. Xiamen Amoytop Biotech's EBIT is CN¥712.2M making its interest coverage ratio -80.6. It has cash and short-term investments of CN¥655.4M.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -80.6x |
Cash | CN¥655.38m |
Equity | CN¥2.01b |
Total liabilities | CN¥421.70m |
Total assets | CN¥2.43b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688278's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥347.6M).
Long Term Liabilities: 688278's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥74.1M).
Debt to Equity History and Analysis
Debt Level: 688278 is debt free.
Reducing Debt: 688278 has no debt compared to 5 years ago when its debt to equity ratio was 12.2%.
Debt Coverage: 688278 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 688278 has no debt, therefore coverage of interest payments is not a concern.